Ouadih-Moran, M., Muñoz-Hoyos, A., D'Marco, L., Molina-Carballo, A., Seiquer, I., & Checa-Ros, A. (2023). Is S100B involved in attention-deficit/hyperactivity disorder (ADHD)? comparisons with controls and changes following a triple therapy containing methylphenidate, melatonin and ω-3 PUFAs.

Ouadih-Moran, M., A. Muñoz-Hoyos, L. D'Marco, A. Molina-Carballo, Isabel Seiquer, and A. Checa-Ros. Is S100B Involved in Attention-deficit/hyperactivity Disorder (ADHD)? Comparisons With Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs. 2023.

Ouadih-Moran, M., et al. Is S100B Involved in Attention-deficit/hyperactivity Disorder (ADHD)? Comparisons With Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs. 2023.